Immature lung problems: can our nomenclature be more specific?

L E Swischuk1, S D John

  • 1Department of Radiology, University of Texas Medical Branch, Galveston 77555-0709, USA.

Insights

Premature infants often have underdeveloped lungs (pulmonary hypoplasia) even after surfactant therapy. This structural immaturity leads to breathing difficulties and necessitates long-term ventilator support, causing further complications.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Respiratory Physiology

Background:

  • Surfactant therapy has improved outcomes for hyaline membrane disease.
  • Pulmonary hypoplasia persists in premature infants despite biochemical recovery.
  • Structural lung immaturity limits gas exchange capacity in neonates.

Purpose of the Study:

  • To re-evaluate the terminology used for lung problems in premature infants.
  • To better reflect the pathophysiology of chronic lung disease in neonates.
  • To address the persistent challenges of pulmonary hypoplasia post-surfactant therapy.

Main Methods:

  • Review of clinical data and outcomes in premature infants.
  • Analysis of the pathophysiology of neonatal lung immaturity.
  • Literature review on current terminology and its accuracy.

Main Results:

  • Premature infants often exhibit pulmonary hypoplasia, characterized by reduced alveoli count.
  • Inadequate gas exchange necessitates prolonged mechanical ventilation.
  • Ventilator-associated complications include hypoxia, oxygen toxicity, and barotrauma.

Conclusions:

  • Current terminology may not accurately describe the structural lung issues in recovering premature infants.
  • Revised terminology is needed to better align with the pathophysiology of neonatal lung immaturity.
  • Addressing pulmonary hypoplasia is crucial for improving long-term respiratory outcomes in preterm neonates.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...